SCUBE1 Controls BMPR2-Relevant Pulmonary Endothelial Function: Implications for Diagnostic Marker Development in Pulmonary Arterial Hypertension.
SCUBE1 Controls BMPR2-Relevant Pulmonary Endothelial Function: Implications for Diagnostic Marker Development in Pulmonary Arterial Hypertension.
复制标题
DOI:
10.1016/j.jacbts.2020.08.010
复制
发表时间:
2020-11
期刊:
影响因子:
--
通讯作者:
Chan SY
中科院分区:
文献类型:
--
作者:
Sun W;Tang Y;Tai YY;Handen A;Zhao J;Speyer G;Al Aaraj Y;Watson A;Romanelli ME;Sembrat J;Rojas M;Simon MA;Zhang Y;Lee J;Xiong Z;Dutta P;Vasamsetti SB;McNamara D;McVerry B;McTiernan CF;Sciurba FC;Kim S;Smith KA;Mazurek JA;Han Y;Vaidya A;Nouraie SM;Kelly NJ;Chan SY
Guided by public sequencing data of iPSC-derived BMPR2-mutant ECs derived from patients with PAH and related family members, SCUBE1 was found to be differentially expressed in ECs carrying BMPR2 mutations, dependent on HIF1A and down-regulated by PAH triggers. SCUBE1 deficiency controlled BMPR2-associated SMAD1/5/9 signaling, thus regulating endothelial angiogenic potential, proliferation, and apoptosis. SCUBE1 was decreased specifically in plasma and lungs in rodents and patients with PAH but not in those with PH due to left heart disease or other acute or chronic pulmonary and cardiovascular diseases. A plasma SCUBE1 cutpoint of 5.46 ng/ml was defined to distinguish PAH from non-PAH contexts, with a high specificity (0.87) and a significant diagnostic OR (7.6). In PAH patients, plasma SCUBE1 levels negatively correlated with PA pressure, pulmonary vascular resistance, and RV dysfunction. These findings support the notion of SCUBE1 as a clinical biomarker of PAH, reflecting the severity and progression of PAH and inherently linked to disease pathogenesis and genetic predisposition. Utilizing publicly available ribonucleic acid sequencing data, we identified SCUBE1 as a BMPR2-related gene differentially expressed between induced pluripotent stem cell-endothelial cells derived from pulmonary arterial hypertension (PAH) patients carrying pathogenic BMPR2 mutations and control patients without mutations. Endothelial SCUBE1 expression was decreased by known triggers of PAH, and its down-regulation recapitulated known BMPR2-associated endothelial pathophenotypes in vitro. Meanwhile, SCUBE1 concentrations were reduced in plasma obtained from PAH rodent models and patients with PAH, whereas plasma concentrations were tightly correlated with hemodynamic markers of disease severity. Taken together, these data implicate SCUBE1 as a novel contributor to PAH pathogenesis with potential therapeutic, diagnostic, and prognostic applications.
登录
查看更多内容
影响因子:
23.9
作者:
Gu M;Shao NY;Sa S;Li D;Termglinchan V;Ameen M;Karakikes I;Sosa G;Grubert F;Lee J;Cao A;Taylor S;Ma Y;Zhao Z;Chappell J;Hamid R;Austin ED;Gold JD;Wu JC;Snyder MP;Rabinovitch M
通讯作者:
Rabinovitch M
影响因子:
3.7
作者:
Bauer, Eileen M.;Zheng, Han;Bauer, Philip M.
通讯作者:
Bauer, Philip M.
影响因子:
24
作者:
Machado, Rajiv D.;Eickelberg, Oliver;Elliott, C. Gregory;Geraci, Mark W.;Hanaoka, Masayuki;Loyd, James E.;Newman, John H.;Phillips, John A., III;Soubrier, Florent;Trembath, Richard C.;Chung, Wendy K.
通讯作者:
Chung, Wendy K.
影响因子:
46.9
作者:
Love, Michael I.;Hogenesch, John B.;Irizarry, Rafael A.
通讯作者:
Irizarry, Rafael A.
影响因子:
9.6
作者:
Benza, Raymond L.;Miller, Dave P.;McGoon, Michael D.
通讯作者:
McGoon, Michael D.